vs
林德（LIN）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
林德的季度营收约是Arcus Biosciences, Inc.的798.3倍（$8.8B vs $11.0M），林德同比增速更快（8.2% vs -52.2%），林德自由现金流更多（$898.0K vs $-121.0M），过去两年Arcus Biosciences, Inc.的营收复合增速更高（4.9% vs 3.1%）
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
LIN vs RCUS — 直观对比
营收规模更大
LIN
是对方的798.3倍
$11.0M
营收增速更快
LIN
高出60.4%
-52.2%
自由现金流更多
LIN
多$121.9M
$-121.0M
两年增速更快
RCUS
近两年复合增速
3.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.8B | $11.0M |
| 净利润 | — | $-106.0M |
| 毛利率 | 48.5% | — |
| 营业利润率 | 27.8% | -1036.4% |
| 净利率 | — | -963.6% |
| 营收同比 | 8.2% | -52.2% |
| 净利润同比 | — | -12.8% |
| 每股收益（稀释后） | $3.98 | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINRCUS
| Q1 26 | $8.8B | — | ||
| Q4 25 | $8.8B | $11.0M | ||
| Q3 25 | $8.6B | $6.0M | ||
| Q2 25 | $8.5B | $8.0M | ||
| Q1 25 | $8.1B | $8.0M | ||
| Q4 24 | $8.3B | $23.0M | ||
| Q3 24 | $8.4B | $7.0M | ||
| Q2 24 | $8.3B | $11.0M |
净利润LINRCUS
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $-106.0M | ||
| Q3 25 | $1.9B | $-135.0M | ||
| Q2 25 | $1.8B | $0 | ||
| Q1 25 | $1.7B | $-112.0M | ||
| Q4 24 | $1.7B | $-94.0M | ||
| Q3 24 | $1.6B | $-92.0M | ||
| Q2 24 | $1.7B | $-93.0M |
毛利率LINRCUS
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率LINRCUS
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -1036.4% | ||
| Q3 25 | 27.5% | -2366.7% | ||
| Q2 25 | 27.7% | -100.0% | ||
| Q1 25 | 26.9% | -1525.0% | ||
| Q4 24 | 27.4% | -447.8% | ||
| Q3 24 | 25.0% | -1500.0% | ||
| Q2 24 | 26.4% | -963.6% |
净利率LINRCUS
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | -963.6% | ||
| Q3 25 | 22.4% | -2250.0% | ||
| Q2 25 | 20.8% | — | ||
| Q1 25 | 20.6% | -1400.0% | ||
| Q4 24 | 20.8% | -408.7% | ||
| Q3 24 | 18.5% | -1314.3% | ||
| Q2 24 | 20.1% | -845.5% |
每股收益（稀释后）LINRCUS
| Q1 26 | $3.98 | — | ||
| Q4 25 | $3.28 | $-0.88 | ||
| Q3 25 | $4.09 | $-1.27 | ||
| Q2 25 | $3.73 | $0.00 | ||
| Q1 25 | $3.51 | $-1.14 | ||
| Q4 24 | $3.61 | $-1.07 | ||
| Q3 24 | $3.22 | $-1.00 | ||
| Q2 24 | $3.44 | $-1.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0B | $222.0M |
| 总债务越低越好 | $24.7B | $99.0M |
| 股东权益账面价值 | $40.1B | $631.0M |
| 总资产 | $86.3B | $1.1B |
| 负债/权益比越低杠杆越低 | 0.62× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资LINRCUS
| Q1 26 | $4.0B | — | ||
| Q4 25 | $5.1B | $222.0M | ||
| Q3 25 | $4.5B | $238.0M | ||
| Q2 25 | $4.8B | $248.0M | ||
| Q1 25 | $5.3B | $192.0M | ||
| Q4 24 | $4.8B | $150.0M | ||
| Q3 24 | $5.2B | $201.0M | ||
| Q2 24 | $4.6B | $156.0M |
总债务LINRCUS
| Q1 26 | $24.7B | — | ||
| Q4 25 | $20.7B | $99.0M | ||
| Q3 25 | $18.6B | $98.0M | ||
| Q2 25 | $19.7B | $97.0M | ||
| Q1 25 | $17.6B | $48.0M | ||
| Q4 24 | $15.3B | $48.0M | ||
| Q3 24 | $17.5B | $47.0M | ||
| Q2 24 | $16.9B | — |
股东权益LINRCUS
| Q1 26 | $40.1B | — | ||
| Q4 25 | $38.2B | $631.0M | ||
| Q3 25 | $38.6B | $436.0M | ||
| Q2 25 | $38.5B | $549.0M | ||
| Q1 25 | $38.0B | $531.0M | ||
| Q4 24 | $38.1B | $485.0M | ||
| Q3 24 | $39.2B | $565.0M | ||
| Q2 24 | $38.2B | $635.0M |
总资产LINRCUS
| Q1 26 | $86.3B | — | ||
| Q4 25 | $86.8B | $1.1B | ||
| Q3 25 | $86.0B | $974.0M | ||
| Q2 25 | $86.1B | $1.1B | ||
| Q1 25 | $82.7B | $1.2B | ||
| Q4 24 | $80.1B | $1.1B | ||
| Q3 24 | $82.5B | $1.3B | ||
| Q2 24 | $80.2B | $1.2B |
负债/权益比LINRCUS
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | 0.16× | ||
| Q3 25 | 0.48× | 0.22× | ||
| Q2 25 | 0.51× | 0.18× | ||
| Q1 25 | 0.46× | 0.09× | ||
| Q4 24 | 0.40× | 0.10× | ||
| Q3 24 | 0.45× | 0.08× | ||
| Q2 24 | 0.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | $898.0K | $-121.0M |
| 自由现金流率自由现金流/营收 | 0.0% | -1100.0% |
| 资本支出强度资本支出/营收 | — | 9.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | — |
8季度趋势，按日历期对齐
经营现金流LINRCUS
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-120.0M | ||
| Q3 25 | $2.9B | $-97.0M | ||
| Q2 25 | $2.2B | $-133.0M | ||
| Q1 25 | $2.2B | $-132.0M | ||
| Q4 24 | $2.8B | $-100.0M | ||
| Q3 24 | $2.7B | $26.0M | ||
| Q2 24 | $1.9B | $-94.0M |
自由现金流LINRCUS
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | $-121.0M | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $954.0M | — | ||
| Q1 25 | $891.0M | $-133.0M | ||
| Q4 24 | $1.6B | $-101.0M | ||
| Q3 24 | $1.7B | $25.0M | ||
| Q2 24 | $796.0M | — |
自由现金流率LINRCUS
| Q1 26 | 0.0% | — | ||
| Q4 25 | 17.9% | -1100.0% | ||
| Q3 25 | 19.4% | — | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | 11.0% | -1662.5% | ||
| Q4 24 | 18.8% | -439.1% | ||
| Q3 24 | 19.9% | 357.1% | ||
| Q2 24 | 9.6% | — |
资本支出强度LINRCUS
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | 9.1% | ||
| Q3 25 | 14.8% | 0.0% | ||
| Q2 25 | 14.8% | 0.0% | ||
| Q1 25 | 15.7% | 12.5% | ||
| Q4 24 | 15.1% | 4.3% | ||
| Q3 24 | 12.8% | 14.3% | ||
| Q2 24 | 13.7% | 0.0% |
现金转化率LINRCUS
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.29× | — | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.76× | — | ||
| Q2 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIN
暂无分部数据
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
